Internal J&J Emails Detail “Ugly” Chapter in Mismarketing of Antipsychotics
BNET By Jim Edwards March 25, 2011 One of the reasons Johnson & Johnson (JNJ) lost a recent trial verdict over its misleading marketing of…
BNET By Jim Edwards March 25, 2011 One of the reasons Johnson & Johnson (JNJ) lost a recent trial verdict over its misleading marketing of…
The risk of coronary heart disease and a cluster of conditions known as metabolic syndrome increases soon after otherwise healthy, but depressed people are started on psychiatric drugs, putting them at risk for an early death, Canadian researchers are reporting.